Alpha IVF Group Bhd (XKLS:0303) ROE %: 26.28% (As of Feb. 2026) — 23% Below Median


XKLS:0303 Alpha IVF Group Bhd XKLS:0303
50 GF Score
Price RM0.25
View Full Analysis

What is Alpha IVF Group Bhd ROE %?

Alpha IVF Group Bhd XKLS:0303 +2.08% 50 ROE % is 26.28% as of Feb. 2026, which is 23% below its 10-year median of 34.19. GuruFocus rates XKLS:0303 with a GF Score™ of 50/100. Among 623 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks better than 91.81% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Alpha IVF Group Bhd's annualized net income for the quarter that ended in Feb. 2026 was RM49.8 Mil. Alpha IVF Group Bhd's average Total Stockholders Equity over the quarter that ended in Feb. 2026 was RM189.6 Mil. Therefore, Alpha IVF Group Bhd's annualized ROE % for the quarter that ended in Feb. 2026 was 26.28%.

The historical rank and industry rank for Alpha IVF Group Bhd's ROE % or its related term are showing as below:

XKLS:0303' s ROE % Range Over the Past 10 Years
Min: -12.17   Med: 34.19   Max: 115.67
Current: 29.42

During the past 6 years, Alpha IVF Group Bhd's highest ROE % was 115.67%. The lowest was -12.17%. And the median was 34.19%.

XKLS:0303's ROE % is ranked better than
91.81% of 623 companies
in the Healthcare Providers & Services industry
Industry Median: 5.86 vs XKLS:0303: 29.42

Alpha IVF Group Bhd  (XKLS:0303) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Feb. 2026 )
=Net Income/Total Stockholders Equity
=49.828/189.609
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(49.828 / 188.492)*(188.492 / 266.614)*(266.614 / 189.609)
=Net Margin %*Asset Turnover*Equity Multiplier
=26.44 %*0.707*1.4061
=ROA %*Equity Multiplier
=18.69 %*1.4061
=26.28 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Feb. 2026 )
=Net Income/Total Stockholders Equity
=49.828/189.609
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (49.828 / 67.892) * (67.892 / 71.656) * (71.656 / 188.492) * (188.492 / 266.614) * (266.614 / 189.609)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7339 * 0.9475 * 38.02 % * 0.707 * 1.4061
=26.28 %

Note: The net income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Alpha IVF Group Bhd ROE % Related Terms


Alpha IVF Group Bhd ROE % Historical Data

* Premium members only.

The historical data trend for Alpha IVF Group Bhd's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha IVF Group Bhd ROE % Chart

Alpha IVF Group Bhd Annual Data
Trend May20 May21 May22 May23 May24 May25
ROE %
Get a 7-Day Free Trial -12.17 38.57 115.67 44.29 29.81

Alpha IVF Group Bhd Quarterly Data
May20 May21 May22 May23 Oct23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.26 33.80 31.61 24.91 26.28

XKLS:0303 vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha IVF Group Bhd ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's ROE % distribution charts can be found below:

* The bar in red indicates where Alpha IVF Group Bhd's ROE % falls into.


XKLS:0303
50GF Score
Alpha IVF Group Bhd XKLS:0303
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha IVF Group Bhd ROE % Calculation

Alpha IVF Group Bhd's annualized ROE % for the fiscal year that ended in May. 2025 is calculated as

ROE %=Net Income (A: May. 2025 )/( (Total Stockholders Equity (A: May. 2024 )+Total Stockholders Equity (A: May. 2025 ))/ count )
=57.453/( (187.434+198.038)/ 2 )
=57.453/192.736
=29.81 %

Alpha IVF Group Bhd's annualized ROE % for the quarter that ended in Feb. 2026 is calculated as

ROE %=Net Income (Q: Feb. 2026 )/( (Total Stockholders Equity (Q: Nov. 2025 )+Total Stockholders Equity (Q: Feb. 2026 ))/ count )
=49.828/( (196.623+182.595)/ 2 )
=49.828/189.609
=26.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Feb. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 26.28% mean?
Alpha IVF Group Bhd (XKLS:0303) has a ROE % of 26.28% as of Feb. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Alpha IVF Group Bhd and its competitors. This is 23% below median its historical median of 34.19. According to the industry distribution chart, Alpha IVF Group Bhd ranks #51 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 8.2%.
Is Alpha IVF Group Bhd's ROE % too high?
Alpha IVF Group Bhd's current ROE % of 26.28% is 23% below median its 10-year median of 34.19. The Healthcare Providers & Services industry median ROE % is 5.86. Alpha IVF Group Bhd's value of 26.28% is 348.5% above this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #51 out of 623 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha IVF Group Bhd has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #51 out of 623 companies for ROE %. This places Alpha IVF Group Bhd in the top 8% of its industry — outperforming the majority of peers. The industry median ROE % is 5.86. Alpha IVF Group Bhd's value of 26.28% is 348.5% above this benchmark. While the company's 10-year median is 34.19 vs. the industry median of 5.86, Alpha IVF Group Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.86, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current ROE % of 26.28% is 348.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Alpha IVF Group Bhd and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current ROE % is 26.28%, which is 23% below median its own 10-year median of 34.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current ROE % of 26.28%. The current ROE % is 26.28%, which is 23% below median its 10-year median of 34.19 and 348.5% above the Healthcare Providers & Services industry median of 5.86. Alpha IVF Group Bhd's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current ROE % is 26.28% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha IVF Group Bhd Business Description

Address Jalan PJU 5/22, G01, Ground Floor, Encorp Strand Mall, Kota Damansara, Darul Ehsan, Petaling Jaya, SGR, MYS, 47810
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
50GF Score

Get the complete analysis for XKLS:0303

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.25
Price